Skip to main content

Advertisement

Log in

The socio-economic impact of work disability due to inflammatory bowel disease in Brazil

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

Background

Inflammatory bowel disease (IBD) might have economic and social impacts in Brazil, where its prevalence has increased recently. This study aimed to assess disability due to IBD in the Brazilian population and demographic factors potentially associated with absence from work.

Methods

Analysis was performed using the computerized Single System of Social Security Benefits Information, with a cross-check for aid pension and disability retirement, for Crohn’s disease (CD) and ulcerative colitis (UC). Additional data were obtained from the platform, including the average values, benefit duration, age, gender and region of the country.

Results

Temporary disability occurred more frequently with UC, whereas permanent disability was more frequent with CD. Temporary disability affected more younger patients with CD than patients with UC. Temporary work absences due to UC and CD were greater in the South, and the lowest absence rates due to CD were noted in the North and Northeast. Absence from work was longer (extending for nearly a year) in patients with CD compared to those with UC. The rates of temporary and permanent disability were greater among women. Permanent disability rates were higher in the South (UC) and Southeast (CD). The value of benefits paid for IBD represented approximately 1% of all social security benefits. The benefits paid for CD were higher than for UC, whereas both tended to decrease from 2010 to 2014.

Conclusions

In Brazil, IBD frequently causes disability for prolonged periods and contributes to early retirement. Reduction trends may reflect improvements in access to health care and medication. Vocational rehabilitation programs may positively impact social security and the patients’ quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

IBD:

Inflammatory bowel disease

CD:

Crohn’s disease

UC:

Ulcerative colitis

INSS:

National Institute of Social Security

SUIBE:

Unified Benefits Information System

References

  1. Abraham, B.P., Sellin, J.H.: Disability in inflammatory bowel disease. Gastroenterol. Clin. North Am. 41, 429–441 (2012)

    Article  PubMed  Google Scholar 

  2. Ananthakrishnan, A.N., Weber, L.R., Knox, J.F., et al.: Permanent work disability in Crohn’s disease. Am. J. Gastroenterol. 103, 154–161 (2008)

    Article  PubMed  Google Scholar 

  3. Bassi, A., Dodd, S., Williamson, P., et al.: Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 53, 1471–1478 (2004)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Bernklev, T., Jahnsen, J., Henriksen, M., et al.: Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 12, 402–412 (2006)

    Article  PubMed  Google Scholar 

  5. Bodger, K., Yen, L., Szende, A., et al.: Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysis. Eur. J. Gastroenterol. Hepatol. 26, 213–221 (2014)

    Article  PubMed  Google Scholar 

  6. Boonen, A., Dagnelie, P.C., Feleus, A., et al.: The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm. Bowel Dis. 8, 382–389 (2002)

    Article  PubMed  Google Scholar 

  7. Burisch, J., Jess, T., Martinato, M., et al.: The burden of inflammatory bowel disease in Europe. J. Crohn’s Colitis 7, 322–337 (2013)

    Article  Google Scholar 

  8. Calsbeek, H., Rijken, M., Dekker, J., et al.: Disease characteristics as determinants of the labour market position of adolescents and young adults with chronic digestive disorders. Eur. J. Gastroenterol. Hepatol. 18, 203–209 (2006)

    Article  PubMed  Google Scholar 

  9. Cho, J.H.: The genetics and immunopathogenesis of inflammatory bowel disease. Nat. Rev. Immunol. 8, 458–466 (2008)

    Article  CAS  PubMed  Google Scholar 

  10. Cohen, R.D., Yu, A.P., Wu, E.Q., et al.: Systematic review: the costs of ulcerative colitis in Western countries. Aliment. Pharmacol. Ther. 31, 693–707 (2010)

    Article  CAS  PubMed  Google Scholar 

  11. De Boer, A.G., Bennebroek Evertsz, F., Stokkers, P.C., et al.: Employment status, difficulties at work and quality of life in inflammatory bowel disease patients. Eur. J. Gastroenterol. Hepatol. 28, 1130–1136 (2016)

    Article  PubMed  Google Scholar 

  12. Floyd, D.N., Langham, S., Severac, H.C., et al.: The economic and quality-of-life burden of Crohn’s disease in Europe and the United States, 2000 to 2013: a systematic review. Dig. Dis. Sci. 60, 299–312 (2015)

    Article  PubMed  Google Scholar 

  13. Ganz, M.L., Sugarman, R., Wang, R., et al.: The economic and health-related impact of Crohn’s disease in the United States: evidence from a nationally representative survey. Inflamm. Bowel Dis. 22, 1032–1041 (2016)

    Article  PubMed  Google Scholar 

  14. Hoivik, M.L., Moum, B., Solberg, I.C., et al.: Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 62, 368–375 (2013)

    Article  PubMed  Google Scholar 

  15. Kaplan, G.G.: The global burden of IBD: from 2015 to 2025. Nat. Rev. Gastroenterol. Hepatol. 12, 720–727 (2015)

    Article  PubMed  Google Scholar 

  16. Kappelman, M.D., Rifas-Shiman, S.L., Porter, C.Q., et al.: Direct health care costs of Crohn’s disease and ulcerative colitis in US children and adults. Gastroenterology 135, 1907–1913 (2008)

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kawalec, P.: Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review. Arch. Med. Sci. AMS 12, 295–302 (2016)

    Article  PubMed  Google Scholar 

  18. Kawalec, P., Malinowski, K.P.: Indirect health costs in ulcerative colitis and Crohn’s disease: a systematic review and meta-analysis. Expert Rev. Pharmacoecon. Outcomes Res. 15, 253–266 (2015)

    Article  PubMed  Google Scholar 

  19. Knights, D., Lassen, K.G., Xavier, R.J.: Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 62, 1505–1510 (2013)

    Article  CAS  PubMed  Google Scholar 

  20. Kvien, T.K.: Epidemiology and burden of illness of rheumatoid arthritis. PharmacoEconomics 22, 1–12 (2004)

    Article  PubMed  Google Scholar 

  21. Lidgren, M., Wilking, N., Jonsson, B.: Cost of breast cancer in Sweden in 2002. Eur. J. Health Econ. HEPAC Health Econ. Prev. Care 8, 5–15 (2007)

    Article  Google Scholar 

  22. Magro, F., Portela, F., Lago, P., et al.: Inflammatory bowel disease: a patient’s and caregiver’s perspective. Dig. Dis. Sci. 54, 2671–2679 (2009)

    Article  CAS  PubMed  Google Scholar 

  23. Mandel, M.D., Balint, A., Lovasz, B.D., et al.: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Eur. J. Health Econ. HEPAC Health Econ. Prev. Care 15(Suppl 1), S121–S128 (2014)

    Google Scholar 

  24. Molodecky, N.A., Soon, I.S., Rabi, D.M., et al.: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46–54 e42 (2012). quiz e30

    Article  PubMed  Google Scholar 

  25. Odes, S., Vardi, H., Friger, M., et al.: Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology 131, 719–728 (2006)

    Article  PubMed  Google Scholar 

  26. Rocchi, A., Benchimol, E.I., Bernstein, C.N., et al.: Inflammatory bowel disease: a Canadian burden of illness review. Can. J. Gastroenterol. J. Can. de Gastroenterol. 26, 811–817 (2012)

    Article  Google Scholar 

  27. Rosch, M., Leidl, R., Thomas, S., et al.: Measurement of outpatient treatment costs of chronic inflammatory bowel diseases at a German university hospital. Med. Klin. 97, 128–136 (2002)

    Article  Google Scholar 

  28. Russel, M.G., Ryan, B.M., Dagnelie, P.C., et al.: Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study. Gut 52, 358–362 (2003)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Schmid, A., Pugin, J., Chevrolet, J.C., et al.: Burden of illness imposed by severe sepsis in Switzerland. Swiss Med. Wkly. 134, 97–102 (2004)

    CAS  PubMed  Google Scholar 

  30. Siebert, U., Wurm, J., Gothe, R.M., et al.: Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflamm. Bowel Dis. 19, 847–855 (2013)

    Article  PubMed  Google Scholar 

  31. Sonnenberg, A.: Disability from inflammatory bowel disease among employees in West Germany. Gut 30, 367–370 (1989)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Stark, R., Konig, H.H., Leidl, R.: Costs of inflammatory bowel disease in Germany. PharmacoEconomics 24, 797–814 (2006)

    Article  PubMed  Google Scholar 

  33. Stjernman, H., Tysk, C., Almer, S., et al.: Unfavourable outcome for women in a study of health-related quality of life, social factors and work disability in Crohn’s disease. Eur. J. Gastroenterol. Hepatol. 23, 671–679 (2011)

    Article  PubMed  Google Scholar 

  34. Timmer, A.: How often and for how long are IBD patients expected to be sick, off work, or in hospital each year? Inflamm. Bowel Dis. 14(Suppl 2), S48–S49 (2008)

    Article  PubMed  Google Scholar 

  35. Van Der Valk, M.E., Mangen, M.J., Leenders, M., et al.: Risk factors of work disability in patients with inflammatory bowel disease—a Dutch nationwide web-based survey: work disability in inflammatory bowel disease. J. Crohn’s Colitis 8, 590–597 (2014)

    Article  Google Scholar 

  36. Van Der Valk, M.E., Mangen, M.J., Severs, M., et al.: Evolution of costs of inflammatory bowel disease over two years of follow-up. PLoS One 11, e0142481 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  37. Yu, A.P., Cabanilla, L.A., Wu, E.Q., et al.: The costs of Crohn’s disease in the United States and other Western countries: a systematic review. Curr. Med. Res. Opin. 24, 319–328 (2008)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Drs. Paula Regina Soares Malta and Roseane Teles Correia for technical assistance, the Instituto Nacional do Seguro Social (INSS) for granting access to the database of social security, and the Brazilian research foundations Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) for financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heitor S. de Souza.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de S. B. Fróes, R., Carvalho, A.T.P., de V. Carneiro, A.J. et al. The socio-economic impact of work disability due to inflammatory bowel disease in Brazil. Eur J Health Econ 19, 463–470 (2018). https://doi.org/10.1007/s10198-017-0896-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-017-0896-4

Keywords

JEL Classification

Navigation